Cargando…
1825. Comparative Effectiveness of Ampicillin versus Vancomycin or Daptomycin for the Treatment of Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections
BACKGROUND: Treatment options against Enterococcus spp., a common nosocomial pathogen, are limited due to intrinsic resistance to multiple antibiotics. Ampicillin is considered drug of choice if susceptible, but data comparing outcomes between ampicillin, daptomycin, and vancomycin for ampicillin-se...
Autores principales: | Chua, Hubert C, Phe, Kady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752009/ http://dx.doi.org/10.1093/ofid/ofac492.1455 |
Ejemplares similares
-
1826. Comparative Use of Vancomycin versus Ampicillin for Blood Stream Infections Caused by Ampicillin-susceptible Enterococcus faecalis
por: Phan, Michaele, et al.
Publicado: (2022) -
Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections
por: Hemapanpairoa, Jatapat, et al.
Publicado: (2022) -
273. Comparative Effectiveness of Ampicillin in the Treatment of Enterococcus faecalis Bloodstream Infections in Patients With Cancer
por: Sanchez, J P, et al.
Publicado: (2020) -
Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility
por: Coyne, Ashlan J. Kunz, et al.
Publicado: (2022) -
370. The comparison of adverse events in combination with double beta-lactam antimicrobials: Ampicillin plus Ceftriaxone and Ampicillin/Cloxacillin with bloodstream infections
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)